Phase 2Data readout

SPY072 (SPY002-072) (TL1A Antibody)

Hidradenitis Suppurativa

SYRESpyre Therapeutics Inc

Expected catalystDecember 31, 2027Company guidance: Dec 31, 2027

Catalyst overview

Event details

Drug or asset: SPY072 (SPY002-072) (TL1A Antibody)
Development stage: Phase 2
Event type: Data readout
Indication: Hidradenitis Suppurativa

Research summary

What is being tracked?

This catalyst tracks a Phase 2 data readout for SPY072 (SPY002-072) (TL1A Antibody) in Hidradenitis Suppurativa. The expected timing is based on the latest available company guidance and may change.

Development notes

08/10/26:- Ph2 SKYLIGHT HS trial initiated; topline Week 16 HiSCR75 data expected Late 2027/Early 2028.

Verification

Primary source

Confirm timing and program details against the company announcement or filing.

Open source

SPY072 (SPY002-072) (TL1A Antibody)

Event details

What is being tracked?

Development notes

Primary source

Related pipeline programs

SPY003

SPY001 (α4β7)

SPY002 (SPY002-091) (TL1A)

SPY072 (SPY002-072)